Mazabraud Yann
SEC CIK 1774702 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | EVP, Head of International | 112.7K | — | $12.88M | 23 | 2022-02-11 | 2026-08-12 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-14 19:01 | 2026-08-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | $6.80 | +46.6K | 112.7K | +71% | +$317.1K |
| DMT | 2026-08-14 19:01 | 2026-08-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale+OE | $116.15 | -57.0K | 55.7K | -51% | -$6.62M |
| D | 2026-04-03 17:36 | 2026-04-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +12.9K | 66.0K | +24% | — |
| D | 2026-02-18 | 2026-02-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +10.0K | 53.2K | +23% | — |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +5,500 | 43.2K | +15% | — |
| 2025-05-01 | 2025-04-29 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale | $65.08 | -6,745 | 37.7K | -15% | -$439.0K | |
| DM | 2025-04-16 | 2025-04-14+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +21.8K | 44.4K | +96% | — |
| M | 2025-04-10 | 2025-04-08 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale | $60.98 | -17.8K | 22.6K | -44% | -$1.08M |
| DM | 2025-03-18 | 2025-03-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale+OE | $51.48 | -75.0K | 96.2K | -44% | -$3.86M |
| D | 2025-03-18 | 2025-03-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | $22.28 | +75.0K | 115.4K | +186% | +$1.67M |
| D | 2025-02-19 | 2025-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +5,500 | 40.4K | +16% | — |
| D | 2024-04-16 | 2024-04-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | -10.4K | 34.9K | -23% | — |
| 2024-03-19 | 2024-03-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale | $39.22 | -16.0K | 24.5K | -40% | -$627.5K | |
| D | 2024-02-21 | 2024-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | A - Grant | $0.00 | +33.8K | 40.5K | +500% | $0 |
| DM | 2024-02-13 | 2024-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +5,469 | 9,296 | +143% | — |
| DM | 2024-02-13 | 2024-02-12+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale+OE | $50.80 | -2,551 | 6,745 | -27% | -$129.6K |
| 2023-02-16 | 2023-02-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale | $27.03 | -1,177 | 3,827 | -24% | -$31.8K | |
| A | 2023-02-14 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale | $27.51 | -1,563 | 2,973 | -34% | -$43.0K |
| D | 2023-02-14 | 2023-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +2,031 | 5,004 | +68% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale+OE | $27.66 | -1,548 | 2,988 | -34% | -$42.8K |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +3,438 | 4,536 | +313% | — |
| D | 2022-02-15 | 2022-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +2,032 | 2,032 | New | — |
| D | 2022-02-15 | 2022-02-15 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | S - Sale+OE | $6.10 | -934 | 1,098 | -46% | -$5,697 |
Purchase Sale Sale after option exercise All abbreviations